275 related articles for article (PubMed ID: 31034530)
1. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
[TBL] [Abstract][Full Text] [Related]
2. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.
Stvilia K; Spradling PR; Asatiani A; Gogia M; Kutateladze K; Butsashvili M; Zarkua J; Tsertsvadze T; Sharvadze L; Japaridze M; Kuchuloria T; Gvinjilia L; Tskhomelidze I; Gamkrelidze A; Khonelidze I; Sergeenko D; Shadaker S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(29):637-641. PubMed ID: 31344021
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.
Falade-Nwulia O; Irvin R; Merkow A; Sulkowski M; Niculescu A; Olsen Y; Stoller K; Thomas DL; Latkin C; Mehta SH
J Subst Abuse Treat; 2019 May; 100():45-51. PubMed ID: 30898327
[TBL] [Abstract][Full Text] [Related]
5. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
[TBL] [Abstract][Full Text] [Related]
7. Lessons Learned From Global Hepatitis C Elimination Programs.
Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
[TBL] [Abstract][Full Text] [Related]
8. Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia.
Butsashvili M; Abzianidze T; Kamkamidze G; Gulbiani L; Gvinjilia L; Kuchuloria T; Tskhomelidze I; Gogia M; Tsereteli M; Miollany V; Kikvidze T; Shadaker S; Nasrullah M; Averhoff F
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):23. PubMed ID: 35346265
[TBL] [Abstract][Full Text] [Related]
9. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
[TBL] [Abstract][Full Text] [Related]
10. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs.
Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ
Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
Hagan LM; Kasradze A; Salyer SJ; Gamkrelidze A; Alkhazashvili M; Chanturia G; Chitadze N; Sukhiashvili R; Shakhnazarova M; Russell S; Blanton C; Kuchukhidze G; Baliashvili D; Hariri S; Ko S; Imnadze P; Drobeniuc J; Morgan J; Averhoff F
BMC Public Health; 2019 May; 19(Suppl 3):480. PubMed ID: 32326913
[TBL] [Abstract][Full Text] [Related]
12. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
13. National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
Gvinjilia L; Nasrullah M; Sergeenko D; Tsertsvadze T; Kamkamidze G; Butsashvili M; Gamkrelidze A; Imnadze P; Kvaratskhelia V; Chkhartishvili N; Sharvadze L; Drobeniuc J; Hagan L; Ward JW; Morgan J; Averhoff F
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1132-1135. PubMed ID: 27764081
[TBL] [Abstract][Full Text] [Related]
14. Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial.
Shilton S; Stvilia K; Japaridze M; Tsereteli N; Usharidze D; Phevadze S; Jghenti M; Mozalevskis A; Markby J; Luhmann N; Johnson C; Nabeta P; Ongarello S; Reipold EI; Gamkrelidze A
BMJ Open; 2022 Sep; 12(9):e056243. PubMed ID: 36691209
[TBL] [Abstract][Full Text] [Related]
15. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
[TBL] [Abstract][Full Text] [Related]
16. Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.
Luhmann N; Champagnat J; Golovin S; Maistat L; Agustian E; Inaridze I; Myint WM; Butsashvili M; Bouscaillou J
Int J Drug Policy; 2015 Nov; 26(11):1081-7. PubMed ID: 26342273
[TBL] [Abstract][Full Text] [Related]
17. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
[TBL] [Abstract][Full Text] [Related]
19. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P; Grebely J
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
[TBL] [Abstract][Full Text] [Related]
20. Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in Kenya.
Seu R; Riback LR; Nyakowa M; Lizcano J; Musyoki H; Ross J; Cherutich P; Kurth AE; Akiyama MJ
Glob Public Health; 2022 Dec; 17(12):3627-3637. PubMed ID: 35941717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
